Cite
HARVARD Citation
Hao, D. et al. (n.d.). A Canadian Cancer Trials Group phase IB study of durvalumab with or without tremelimumab + standard platinum-doublet chemotherapy in patients with advanced, incurable solid malignancies (IND.226). European journal of cancer. pp. S95-. [Online].